Adult central nervous system embryonal carcinoma

Summary

Adult central nervous system embryonal carcinoma (MONDO:0004155) is a cancer. A subtype of adult central nervous system germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	adult central nervous system embryonal carcinoma
Mondo ID	MONDO:0004155
DOID	DOID:7233
NCIT	C5790
UMLS	C1370503
MedGen	234580
GARD	0023854
Is cancer (heuristic)	yes

Also known as: adult central nervous system embryonal carcinoma · adult CNS embryonal carcinoma · adult embryonal carcinoma of the central nervous system · Central nervous system embryonal carcinoma · embryonal carcinoma of adult central nervous system · embryonal carcinoma of adult CNS · embryonal carcinoma of the adult central nervous system · embryonal carcinoma of the adult CNS · embryonal carcinoma of the central nervous system of adults

Disease family

This is a subtype of adult central nervous system germ cell tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › central nervous system germ cell tumor › adult central nervous system germ cell tumor › adult central nervous system embryonal carcinoma

Related subtypes (4): adult central nervous system teratoma, adult central nervous system choriocarcinoma, adult central nervous system germinoma, adult central nervous system mixed germ cell tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.